Category Archives: Biology

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies … – GlobeNewswire

MARLBOROUGH, Mass., April 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company, today announced it will highlight case studies featuring its Spatial Biology 2.0 Solutions that enable unprecedented speed and scale for spatial biology studies at the American Association for Cancer Research (AACR) 2024 Annual Meeting in San Diego, April 5 to 10. In addition, the company will showcase new applications of its PhenoCode Signature Panels and preliminary data from the Thermo Fisher ViewRNA assays on Akoyas platforms.

Presentations Showcase the Power of Spatial Biology 2.0

Industry-leading capabilities of the companys spatial biology platforms will be presented during Akoyas Spotlight Theater, titled Spatial Biology 2.0: Spatial Insights and Precision Medicine at Unprecedented Scale on Monday, April 8 at 3 PM (PST). The event will describe how researchers are revealing new insights into the tumor microenvironment, elucidating the mechanisms of cancer treatment response, and paving the way for spatial biology to impact patient outcomes. Deployment of Akoyas PhenoCycler-Fusion 2.0, PhenoImager HT 2.0, and PhenoCode Panels across the research continuum, from ultrahigh-plex discoveries to actionable signatures, will be described by the presenters:

Dr. Kulasinghe will also present a talk entitled Ultra high-plex profiling of the tumor microenvironment on April 6 from 12:36 PM - 12:54 PM PT in Session MW14 - Choosing and Using Antibodies for Spatial Informed Protein Expression. He will discuss the development of ultrahigh-plex antibody panels for the comprehensive characterization of the tumor microenvironment.

Spatial Biology 2.0 Solutions Displayed at Booth #247

Akoya Biosciences will demonstrate new uses of its PhenoCode Signature Panels for accelerating discovery and validation of spatial biomarkers using the PhenoImager HT 2.0 platform. The company will also present initial findings from the Thermo Fisher Scientific ViewRNA assays on the PhenoCycler-Fusion 2.0.

Poster Presentations

Several studies featuring Akoyas Spatial Biology platforms will be described in the following posters:

Monday, April 8: 9:00 AM 12:30 PM

Poster 1525: Integration of high-plex tumor-Immune phenotyping and checkpoint interactions for deeper spatial characterization of human cancer tissues. S. Bodbin, Navinci Diagnostics et al.

Monday, April 8: 1:30 PM 5:00 PM

Poster 3623: Quantifying pharmacodynamic markers of radioligand therapies in tumor by multiplex immunofluorescence and automated quantitative analysis (AQUA) algorithms. J. Santos, Navigate BioPharma Services, Inc. et al.

Poster 3651: Mutational analysis and spatial phenotyping to decipher racial disparities in pancreatic adenocarcinoma; D. J. Salas-Escabillas, University of Michigan et al.

Poster 3763: Comparative spatial analyses of the tumor immune landscape in different mouse models of glioblastoma; D. Klymyshyn, Akoya Biosciences et al.

Tuesday, April 9: 9:00 AM 12:30 PM

Poster 3988: Deep spatial immunophenotyping of lymphoid aggregates in pancreatic cancer using multi-omic integration of ultra high-plex proteomics and transcriptomics; D. Gong, Massachusetts Institute of Technology (MIT) et al.

Poster 5503: Ultrahigh-plex spatial phenotyping of head and neck cancer tissue uncovers multiomic signatures of immunotherapy response; A. Pratapa, Akoya Biosciences et al.

Poster 5504: Integrating ultrahigh-plex spatial phenotyping: From discovery to clinical applications, A. Pratapa; Akoya Biosciences et al.

Tuesday, April 9: 1:30 PM 5:00 PM

Poster 5507: High-resolution spatial atlas reveals insight into spatial landscape of lung cancer and chronic lung diseases; R. Nandigama, Justus Liebig University et al.

Poster 5508: Single-cell spatial landscape of the mutation-specific human lung tumor immune microenvironment; R. Nandigama, Justus Liebig University et al.

Wednesday, April 10: 9:00 AM 12:30 PM

Poster 6738: Overlapping and distinct mechanisms of effective neoantigen cancer vaccines and immune checkpoint therapy; S. Keshari, UT MD Anderson Cancer Center et al.

Poster 6872: A spatio-temporal approach to mapping the dynamics of cutaneous squamous cell carcinoma progression and immunotherapy response: A journey through TiME; N. Jhaveri, Akoya Biosciences et al.

Network of CROs Providing Spatial Biology Services Continues to Grow

Thirteen of Akoyas twenty qualifiedCRO service providerswill also be exhibiting at AACR. Akoyas CRO network continues to grow rapidly, reflecting the demand for spatial phenotyping solutions across the biopharmaceutical industry. Offering biomarker testing services, these CROs enable drug developers and academic research institutions to accelerate the discovery and development of new immuno-therapies.

Full details about Akoyas AACR activities and poster presentations can be found here.

Forward Looking Statements

This press release contains forward-looking statements that are based on managements beliefs and assumptions and on information currently available to management. All statements contained in this release other than statements of historical fact are forward-looking statements, including statements regarding our expectations about the potential and utility of our products and services, the market demand for spatial phenotyping solutions and predictions regarding the future impact of spatial biology.

In some cases, you can identify forward-looking statements by the words may, will, could, would, should, expect, intend, plan, anticipate, believe, estimate, predict, project, potential, continue, ongoing or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. These risks, uncertainties and other factors are described under "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and elsewhere in the documents we file with the Securities and Exchange Commission from time to time. We caution you that forward-looking statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. As a result, the forward-looking statements may not prove to be accurate. The forward-looking statements in this press release represent our views as of the date hereof. We undertake no obligation to update any forward-looking statements for any reason, except as required by law.

About Akoya Biosciences

As The Spatial Biology Company, Akoya Biosciences mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The Company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. To learn more about Akoya, visitwww.akoyabio.com.

Investor Contact:

Priyam Shah Sr. Director, Investor Relations Akoya Biosciences investors@akoyabio.com

Media Contact:

Christine Quern 617-650-8497 media@akoyabio.com

Visit link:

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies ... - GlobeNewswire

BD Increases Access to Cutting-Edge Image-Enabled, Spectral Cell Sorters – BioSpace

New BD FACSDiscover S8 Cell Sorters to Enable More Researchers to Push the Boundaries of Discovery

FRANKLIN LAKES, N.J., April 5, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new cell sorters that will enable more researchers in a broader range of fields, including cell biology, cancer research and immunology, to reveal insights that were previously invisible in traditional flow cytometry experiments.

The new BD FACSDiscover S8 Cell Sorters feature BD CellView Image Technology, profiled on the cover of the journal Science in 2022, and BD SpectralFX Technology bringing to market breakthrough innovations in real-time imaging and spectral flow cytometry. The three- and four-laser additions to the BD FACSDiscover S8 Cell Sorter family complement the five-laser instrument launched last year and provide scientists greater access, options, and flexibility to incorporate real-time imaging and spectral cell sorting technology in their labs.

"For my research in cellular biology, the instrument was perfectly configured when it came to number of lasers and imaging capabilities," said Daniel Schraivogel, Ph.D., a research staff scientist at EMBL, who estimates he had 600 hours working on the three-laser prototype. "It has the same sorting speed and software capabilities as the five-laser unit, making experiments extremely scalable on an easy-to-use instrument."

Using the FACSDiscover S8 Cell Sorters, researchers can confirm complex biological and spatial insights in real time, obtain individual cell images and isolate desired cells based on visual characteristics at high speeds, all within a simplified and easy to use workflow. BD CellView Image Technology improves sort and sample quality, bringing confidence to biological results and saving researchers time and cost in their downstream applications. This expedited time to insight expands capabilities for researchers to transform research and cell-based therapeutic development across numerous fields in drug discovery, immuno-oncology and genomics.

"In flow cytometry, there are often 'suspect' populations where cells are dead or dying, and doublets and cellular debris that can impact the integrity of experiments," Schraivogel continued. "In addition to the added value of spatial information that is needed for many projects in cell biology, infection biology and functional genomic screening, the imaging sorter allows us to better explore our cell populations and is used to validate true single-cell gating and sorting, to deliver better-quality cells and biological outputs."

The family of BD FACSDiscover Cell Sorters will be featured at upcoming conferences beginning with the American Association for Cancer Research (AACR) Annual Meeting, April 5-10, and is now available to order through local sales representatives. More information is available at bdbiosciences.com/S8.

About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at http://www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.

View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-increases-access-to-cutting-edge-image-enabled-spectral-cell-sorters-302108936.html

SOURCE BD (Becton, Dickinson and Company)

Company Codes: NYSE:BDX

Original post:

BD Increases Access to Cutting-Edge Image-Enabled, Spectral Cell Sorters - BioSpace

We’ve had bird evolution all wrong – EurekAlert

image:

A greater flamingo in Mallorca, Spain. Unraveling a genetic mystery revealed that flamingos and doves are more distantly related than previously thought.

Credit: Daniel J. Field

An enormous meteor spelled doom for most dinosaurs 65 million years ago. But not all. In the aftermath of the extinction event, birds technically dinosaurs themselves flourished.

Scientists have spent centuries trying to organize and sort some 10,000 species of birds into one clear family tree to understand how the last surviving dinosaurs filled the skies. Cheap DNA sequencing should have made this simple, as it has for countless other species.

But birds were prepared to deceive us.

In a pair of new research papers released today, April 1, scientists reveal that another event 65 million years ago misled them about the true family history of birds. They discovered that a section of one chromosome spent millions of years frozen in time, and it refused to mix together with nearby DNA as it should have.

This section, just two percent of the bird genome, convinced scientists that most birds could be grouped into two major categories, with flamingos and doves as evolutionary cousins. The more accurate family tree, which accounts for the misleading section of the genome, identifies four main groups and identifies flamingos and doves as more distantly related.

My lab has been chipping away at this problem of bird evolution for longer than I want to think about, said Edward Braun, Ph.D., the senior author of the paper published in the Proceedings of the National Academy of Sciences and a professor of biology at the University of Florida. We had no idea there would be a big chunk of the genome that behaved unusually. We kind of stumbled onto it.

Braun supervised an international team of collaborators led by Siavash Mirarab, a professor of computer engineering at the University of California San Diego, to publish their evidence that this sticky chunk of DNA muddied the true history of bird evolution. Mirarab and Braun also contributed to a companion paper published in Nature that outlines the updated bird family tree, which was led by Josefin Stiller at the University of Copenhagen.

Both papers are part of the B10K avian genomics project led by Guojie Zhang of Zhejiang University, Erich Jarvis of Rockefeller University, and Tom Gilbert of the University of Copenhagen.

Ten years ago, Braun and his collaborators pieced together a family tree for the Neoaves, a group that includes the vast majority of bird species. Based on the genomes of 48 species, they split the Neoaves into two big categories: doves and flamingos in one group, all the rest in the other. When repeating a similar analysis this year using 363 species, a different family tree emerged that split up doves and flamingos into two distinct groups.

With two mutually exclusive family trees in hand, the scientists went hunting for explanations that could tell them which tree was correct.

When we looked at the individual genes and what tree they supported, all of a sudden it popped out that all the genes that support the older tree, theyre all in one spot. Thats what started the whole thing, Braun said.

Investigating this spot, Brauns team noticed it was not as mixed together as it should have been over millions of years of sexual reproduction. Like humans, birds combine genes from a father and a mother into the next generation. But birds and humans alike first mix the genes they inherited from their parents when creating sperm and eggs. This process is called recombination, and it maximizes a species genetic diversity by making sure no two siblings are quite the same.

Brauns team found evidence that one section of one bird chromosome had suppressed this recombination process for a few million years around the time the dinosaurs disappeared. Whether the extinction event and the genomic anomalies are related is unclear.

The result was that the flamingos and doves looked similar to one another in this chunk of frozen DNA. But taking into account the full genome, it became clear that the two groups are more distantly related. Whats surprising is that this period of suppressed recombination could mislead the analysis, Braun said. And because it could mislead the analysis, it was actually detectable more than 60 million years in the future. That's the cool part.

Such a mystery could be lurking in the genomes of other organisms as well.

We discovered this misleading region in birds because we put a lot of energy into sequencing birds genomes, Braun said. I think there are cases like this out there for other species that are just not known right now.

This work was supported in part by the National Science Foundation.

Proceedings of the National Academy of Sciences

Data/statistical analysis

Not applicable

A region of suppressed recombination misleads neoavian phylogenomics

1-Apr-2024

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Here is the original post:

We've had bird evolution all wrong - EurekAlert

Altered brain morphology and functional connectivity in postmenopausal women – EurekAlert

image:

Figure 6.Between-group comparison map (premenopausal women vs. postmenopausal women) of the left mOFC functional connectivity.

Credit: 2024 Kim et al.

[...] our findings suggest that diminished brain volume and functional connectivity may be linked to menopause-related symptoms caused by the lower sex hormone levels.

BUFFALO, NY- April 1, 2024 A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 6, entitled, Altered brain morphology and functional connectivity in postmenopausal women: automatic segmentation of whole-brain and thalamic subnuclei and resting-state fMRI.

The transition to menopause is associated with various physiological changes, including alterations in brain structure and function. However, menopause-related structural and functional changes are poorly understood. In this new study, researchers Gwang-Won Kim, Kwangsung Park, Yun-Hyeon Kim, and Gwang-Woo Jeong from Chonnam National University not only compared the brain volume changes between premenopausal and postmenopausal women, but also evaluated the functional connectivity between the targeted brain regions associated with structural atrophy in postmenopausal women.

To the best of our knowledge, no comparative neuroimaging study on alterations in the brain volume and functional connectivity, especially focusing on the thalamic subnuclei in premenopausal vs. postmenopausal women has been reported.

Each of the 21 premenopausal and postmenopausal women underwent magnetic resonance imaging (MRI). T1-weighted MRI and resting-state functional MRI data were used to compare the brain volume and seed-based functional connectivity, respectively. In statistical analysis, multivariate analysis of variance, with age and whole brain volume as covariates, was used to evaluate surface areas and subcortical volumes between the two groups.

Postmenopausal women showed significantly smaller cortical surface, especially in the left medial orbitofrontal cortex (mOFC), right superior temporal cortex, and right lateral orbitofrontal cortex, compared to premenopausal women (p < 0.05, Bonferroni-corrected) as well as significantly decreased functional connectivity between the left mOFC and the right thalamus was observed (p < 0.005, Monte-Carlo corrected). Although postmenopausal women did not show volume atrophy in the right thalamus, the volume of the right pulvinar anterior, which is one of the distinguished thalamic subnuclei, was significantly decreased (p < 0.05, Bonferroni-corrected).

Postmenopausal women showed significantly lower left mOFC, right lOFC, and right STC surface areas, reduced right PuA volume, and decreased left mOFC-right thalamus functional connectivity compared to premenopausal women. If replicated in an independent sample, these findings will be helpful for understanding the effects of menopause on the altered brain volume and functional connectivity in postmenopausal women.

Read the full study: DOI: https://doi.org/10.18632/aging.205662

Corresponding Author: Gwang-Woo Jeong - gwjeong@jnu.ac.kr

Keywords: brain morphology, functional connectivity, sex hormones, thalamic subnuclei

Click here to sign up for free Altmetric alerts about this article.

About Aging:

Aging publishes research papers in all fields of aging research including but not limited, aging from yeast to mammals, cellular senescence, age-related diseases such as cancer and Alzheimers diseases and their prevention and treatment, anti-aging strategies and drug development and especially the role of signal transduction pathways such as mTOR in aging and potential approaches to modulate these signaling pathways to extend lifespan. The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases, prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.

Aging is indexed by PubMed/Medline (abbreviated as Aging (Albany NY)), PubMed Central, Web of Science: Science Citation Index Expanded (abbreviated as AgingUS and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as Aging and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Please visit our website at http://www.Aging-US.com and connect with us:

Click here to subscribe to Aging publication updates.

For media inquiries, please contact media@impactjournals.com.

Aging (Aging-US) Journal Office

6666 E. Quaker Str., Suite 1B

Orchard Park, NY 14127

Phone: 1-800-922-0957, option 1

###

Observational study

People

Altered brain morphology and functional connectivity in postmenopausal women: automatic segmentation of whole-brain and thalamic subnuclei and resting-state fMRI

23-Mar-2024

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

See more here:

Altered brain morphology and functional connectivity in postmenopausal women - EurekAlert

Research Technician in the Center for Genomics and Systems Biology, Dr. Kristin Gunsalus job with NEW YORK … – Times Higher Education

Description

The Center for Genomics and Systems Biology (CGSB) at New York University Abu Dhabi (NYUAD) is seeking to appoint a full-time Research Technician in the Chemical and Functional Genomics Laboratory under the supervision of Professor Kristin Gunsalus.

The laboratorys research addresses emergent concerns that pose considerable threats to human health and the environment by investigating novel bioactive agents from microbial sources and chemical libraries. Research projects employ High-Throughput (HTP) screening of different biological organisms and High-Content Phenotypic profiling (HCP) of mammalian cells to provide bioactive candidates for the development of novel solutions for contemporary health and environmental challenges. The Research technician will have an integral role within the team providing technical support for operational and research activities. In this role, the key responsibilities of the candidate will include:

The ideal candidate will have a Masters degree in cell & molecular biology or microbiology with at least 3 years of experience in a research lab. The candidate is expected to have hands-on experience in microbiology, molecular biology, cell culture and cell-based assays, with a detailed mind for optimizing assays and generating quality data. Experience in analytical chemistry techniques and natural product extraction from microbes is highly desirable. Experience with high-content or high-throughput screening and lab automation is a plus. The research technician must have a strong work ethic, excellent organizational and communication skills with a high level of proficiency in English, and the ability to work effectively in a team within a multi-disciplinary environment.

The terms of employment include a highly competitive salary, housing allowance, and other benefits. To be considered, all applications must be submitted through Interfolio and should include a cover letter, curriculum vitae, a one-page summary of research accomplishments and interests, two recommendation letters, all in PDF format. If you have any questions, please send your inquiries atnyuad.cgsb.chemgen@nyu.edu

About the CGSB:

The Center for Genomics and Systems Biology (CGSB) at New York University Abu Dhabi was established to provide a nexus for cutting-edge life sciences research in the United Arab Emirates, with world-class facilities and resources to promote innovative advances in genomics and systems biology. The Center fosters and enhances the research and training missions of NYUAD, where undergraduate students, graduate students, and postdoctoral scientists engage in research across disciplines, facilitated by advanced instrumentation and computational support for high-throughput data collection, visualization, and analysis. The NYUAD-CGSB operates in partnership with its sister center, NYU Biologys CGSB, in New York, in an open organizational framework that enables transformative collaborative work across the globe supported by joint technology and service platforms.

About NYUAD:

NYU Abu Dhabi is a degree-granting research university with a fully integrated liberal arts and science undergraduate program in the Arts, Sciences, Social Sciences, Humanities, and Engineering. NYU Abu Dhabi, NYU New York, and NYU Shanghai, form the backbone of NYUs global network university, an interconnected network of portal campuses and academic centers across six continents that enable seamless international mobility of students and faculty in their pursuit of academic and scholarly activity. This global university represents a transformative shift in higher education, one in which the intellectual and creative endeavors of academia are shaped and examined through an international and multicultural perspective. As a major intellectual hub at the crossroads of the Arab world, NYUAD serves as a center for scholarly thought, advanced research, knowledge creation, and sharing, through its academic, research, and creative activities.

EOE/AA/Minorities/Females/Vet/Disabled/Sexual Orientation/Gender Identity Employer

UAE Nationals are encouraged to appl

Equal Employment Opportunity Statement

For people in the EU, click here for information on your privacy rights under GDPR:www.nyu.edu/it/gdpr

NYU is an equal opportunity employer committed to equity, diversity, and social inclusion.

Continued here:

Research Technician in the Center for Genomics and Systems Biology, Dr. Kristin Gunsalus job with NEW YORK ... - Times Higher Education

The Road to Biology 2.0 Will Pass Through Black-Box Data – Towards Data Science

AI-first Biotech This year marks perhaps the zenith of expectations for AI-based breakthroughs in biology, transforming it into an engineering discipline that is programmable, predictable, and replicable. Drawing insights from AI breakthroughs in perception, natural language, and protein structure prediction, we endeavour to pinpoint the characteristics of biological problems that are most conducive to being solved by AI techniques. Subsequently, we delineate three conceptual generations of bio AI approaches in the biotech industry and contend that the most significant future breakthrough will arise from the transition away from traditional white-box data, understandable by humans, to novel high-throughput, low-cost AI-specific black-box data modalities developed in tandem with appropriate computational methods. 46 min read

This post was co-authored with Luca Naef.

The release of ChatGPT by OpenAI in November 2022 has thrust Artificial Intelligence into the global public spotlight [1]. It likely marked the first instance where even people far from the field realised that AI is imminently and rapidly altering the very foundations of how humans will work in the near future [2]. A year down the road, once the limitations of ChatGPT and similar systems have become better understood [3], the initial doom predictions ranging from the more habitual panic about future massive job replacement by AI to declaring OpenAI as the bane of Google, have given place to impatience why is it so slow?, in the words of Sam Altman, the CEO of OpenAI [4]. Familiarity breeds contempt, as the saying goes.

We are now seeing the same frenetic optimism around AI in the biological sciences, with hopes that are probably best summarised by DeepMind

Continued here:

The Road to Biology 2.0 Will Pass Through Black-Box Data - Towards Data Science

Nobel-winning biologist on the most promising ways to stop ageing – New Scientist

ANTI-AGEING is big business. From books encouraging diets such as intermittent fasting to cosmetic creams to combat wrinkles, a multibillion-dollar industry has been built on promises to make us live longer and look younger. But how close are we really to extending our lifespan in a way that gives us extra years of healthy life?

Nobel prizewinner Venki Ramakrishnan, a molecular biologist and former president of the UKs Royal Society, is the latest to tackle this question. He has spent 25 years studying the ribosome, which is where our cells make proteins using the information encoded in our genes, at the MRC Laboratory of Molecular Biology in Cambridge, UK.

In his latest book, Why We Die: The new science of ageing and the quest for immortality, he goes on a journey around the cutting-edge biology of human ageing and asks whether it will be possible to extend our lifespan in the near future.

He talks to New Scientist about the recent breakthroughs in our knowledge of what causes ageing, how close we are to creating therapeutics to combat it, and the potential consequences if we succeed.

Graham Lawton: What inspired you to take a break from a hugely successful career researching how cells make proteins to write a book about ageing?

Venki Ramakrishnan: Two things. One is that the translation of genetic code into proteins affects almost every biological process, and it turns out to be central to many aspects of ageing.

The other reason is that we have worried about ageing and death ever since we

See original here:

Nobel-winning biologist on the most promising ways to stop ageing - New Scientist

How to better research the possible threats posed by AI-driven misuse of biology – Bulletin of the Atomic Scientists

Over the last few months, experts and lawmakers have become increasingly concerned that advances in artificial intelligence could help bad actors develop biological threats. But so far there have been no reported biological misuse examples involving AI or the AI-driven chatbots that have recently filled news headlines. This lack of real-world wrongdoing prevents direct evaluation of the changing threat landscape at the intersection of AI and biology.

Nonetheless, researchers have conducted experiments that aim to evaluate sub-components of biological threatssuch as the ability to develop a plan for or obtain information that could enable misuse. Two recent effortsby RAND Corporation and OpenAIto understand how artificial intelligence could lower barriers to the development of biological weapons concluded that access to a large language model chatbot did not give users an edge in developing plans to misuse biology. But those findings are just one part of the story and should not be considered conclusive.

In any experimental research, study design influences results. Even if technically executed to perfection, all studies have limitations, and both reports dutifully acknowledge theirs. But given the extent of the limitations in the two recent experiments, the reports on them should be seen less as definitive insights and more as opportunities to shape future research, so policymakers and regulators can apply it to help identify and reduce potential risks of AI-driven misuse of biology.

The limitations of recent studies. In the RAND Corporation report, researchers detailed the use of red teaming to understand the impact of chatbots on the ability to develop a plan of biological misuse. The RAND researchers recruited 15 groups of three people to act as red team bad guys. Each of these groups was asked to come up with a plan to achieve one of four nefarious outcomes (vignettes) using biology. All groups were allowed to access the internet. For each of the four vignettes, one red team was given access to an unspecified chatbot and another red team was given access to a different, also unspecified chatbot. When the authors published their final report and accompanying press release in January, they concluded that large language models do not increase the risk of a biological weapons attack by a non-state actor.

This conclusion may be an overstatement of their results, as their focus was specifically on the ability to generate a plan for biological misuse.

The other report was posted by the developers of ChatGPT, OpenAI. Instead of using small groups, OpenAI researchers had participants work individually to identify key pieces of information needed to carry out a specific defined scenario of biological misuse. The OpenAI team reached a conclusion similar to the RAND teams: GPT-4 provides at most a mild uplift in biological threat creation accuracy. Like RAND, this also may be an overstatement of results as the experiment evaluated the ability to access information, not actually create a biological threat.

The OpenAI report was met with mixed reactions, including skepticism and public critique regarding the statistical analysis performed. The core objection was the appropriateness of the use of a correction during analysis that re-defined what constituted a statistically significant result. Without the correction, the results would have been statistically significantthats to say, the use of the chatbot would have been judged to be a potential aid to those interested in creating biological threats.

Regardless of their limitations, the OpenAI and RAND experiments highlight larger questions which, if addressed head-on, would enable future experiments to provide more valuable and actionable results about AI-related biological threats.

Is there more than statistical significance? In both experiments, third-party evaluators assigned numeric scores to the text-based participant responses. The researchers then evaluated if there was a statistically significant difference between those who had access to chatbots and those who did not. Neither research team found one. But typically, the ability to determine if a statistically significant difference exists largely depends on the number of data points; more data points allow for a smaller difference to be considered statistically significant. Therefore, if the researchers had many more participants, the same differences in score could have been statistically significant.

Reducing text to numbers can bring other challenges as well. In the RAND study, the teams, regardless of access to chatbots, did not generate any plans that were deemed likely to succeed. However, there may have been meaningful differences in why the plans were not likely to succeed, and systematically comparing the content of the responses could prove valuable in identifying mitigation measures.

In the OpenAI work, the goal of the participants was to identify a specific series of steps in a plan. However, if a participant were to miss an early step in the plan, all the remaining steps, even if correct, would not count towards their score. This meant that if someone made an error early on, but identified all the remaining information correctly, they would score similarly to someone who did not identify any correct information. Again, researchers may gain insight from identifying patterns in which steps and why participants failed.

Are the results generalizable? To inform an understanding of the threat landscape, conclusions must be generalizable across scenarios and chatbots. Future evaluators should be clear on which large language models are used (the RAND researchers were not). It would be helpful to understand if researchers achieve a similar answer with different models or different answers with the same model. Knowing the specifics would also enable comparisons of results based on the characteristics of the chatbot used, enabling policymakers to understand if models with certain characteristics have unqiue capabilities and impact.

The OpenAI experiment used just one threat scenario. There is not much reason to believe that this one scenario is representative of all threat scenarios; the results may or may not generalize. There is a tradeoff in using one specific scenario; it becomes tenable for one or two people to evaluate 100 responses. On the other hand, the RAND work was much more open-ended as participant teams were given flexibility in how they decided to achieve their intended goal. This makes the results more generalizable, but required a more extensive evaluation procedure that involved many experts to sufficiently examine 15 diverse scenarios.

Are the results impacted by something else? Part way through their experiment, the RAND researchers enrolled a black cell, a group with significant experience with large language models. The RAND researchers made this decision because they noticed that some of their studys red teams were struggling to bypass safety features of the chatbots. In the end, the black cell received an average score almost double that of the corresponding red teams. The black cell participants didnt need to rely only on their expertise with large language models; they were also adept at interpreting the academic literature about those models. This provided a valuable insight to the RAND researchers, which is [t]herelative outperformance of the black cell illustrates that a greater source of variability appears to be red team composition, as opposed to LLM access. Simply put, it probably matters more who is on the team than if the team has access to a large language model or not.

Moving forward. Despite their limitations, red teaming and benchmarking efforts remain valuable tools for understanding the impact of artificial intelligence on the deliberate biological threat landscape. Indeed, the National Institute of Standards and Technologys Artificial Intelligence Safety Institute Consortiuma part of the US Department of Commercecurrently has working groups focused on developing standards and guidelines for this type of research.

Outside of technical design and execution of the experiments, challenges remain. The work comes with meaningful financial costs including the compensation of participants for their time (OpenAI pays $100 per hour to experts); for indviduals to recruit participants, design experiments, administer the experiments, and analyze data; and of biosecurity experts to evaluate the responses. Therefore, it is important to consider who will fund this type of work in the future. Should artificial intelligence companies fund their own studies, a perceived conflict of interest will linger if the results are intended to be used to inform governance or public perception of their models risks. But at the same time, funding that is directed to nonprofits like RAND Corporation or to academia does not inherently enable researchers access to unreleased or modified models, like the version used in the OpenAI experiment. Future work should learn from these two reports, and could benefit from considering the following:

The path toward more useful research on AI and biological threats is hardly free of obstacles. Employees at the National Institute of Standards and Technology have reportedly expressed outrage regarding the recent appointment of Paul Christianoa former OpenAI researcher who has expressed concerns that AI could pose an existential threat to humanityto a leadership role at the Artificial Intelligence Safety Institute. Employees are concerned that Christianos personal beliefs about catastrophic and extistential risk posed by AI broadly will affect his ability to maintain the National Institute of Standards and Technologys commitment to objectivity.

This internal unrest comes on the heels of reporting that the physical buildings that house the institute are falling apart. As Christiano looks to expand his staff, he will also need to compete against the salaries paid by tech companies. OpenAI, for example, is hiring for safety-related roles with the low end of the base salary exceeding the high end of the general service payscale (federal salaries). It is unlikely that any relief will come from the 2024 federal budget, as lawmakers are expected to decrease the institutes budget from 2023 levels. But if the United States wants to remain a global leader in the development of artificial intelligence, it will need to make financial commitments to ensure that the work required to evaluate artificial intelligence is done right.

See the rest here:

How to better research the possible threats posed by AI-driven misuse of biology - Bulletin of the Atomic Scientists

Fired Biology Professor Fights Back and Wins, Has a Message For Fellow Christians – CBN.com

A Texas college professor who said he was fired after university leaders reportedly found his teachings too religious has been reinstated to his position more than a year after being terminated.

Listen to them on the latestepisodeof Quick Start

Dr. Johnson Varkey and his attorneys at First Liberty Institute recently announced Varkey had won his adjunct professorial job back at St. Philips College in San Antonio, Texas, after being fired in 2023 for teaching standard principles about human biology and reproduction.

The announcement comes after a favorable settlement was reached with the Alamo Community College District; the school system voluntarily reinstated Varkey.

I was so excited, the professor told CBN News after the announcement. And thank the Lord for that outcome.

Varkey said hes grateful to First Liberty and to the Lord for helping him get back his position.

I am excited to go back and teach, he said.

Watch Varkey share his story:

As CBN News previously reported, a biology professor for the past 20 years, Varkey consistently taught the same facts about the human reproductive system without any problems. But that changed last year, when he received a notice of dismissal.

I was surprised and I was shocked, because, you know, never expected for such a letter from, or such an email from, the school because Ive been teaching that for that school for the last 20 years and without any complaints, he said.

Varkey believes his lessons on human biology and sex being determined by chromosomes X and Y sparked complaints leading to his dismissal.

On the 12th of January [of 2023], I received an email from the vice president of the department of the school that they are doing an ethic violation investigation on me, so I responded to his email and asked him, What are the complaints?' Varkey said. So, what he said was the human resources will contact me.

The professor said, although he asked about complaints, he received no response from HR and didnt get a chance to defend himself before his firing.

When I got the letter of termination, what the VP mentioned was that some of the complaints were offensive to the homosexuals and transgender, he said. So, I presume that, very possibly, it is based on a human reproductive system, which I taught, which was in November [2022].

Varkey and his attorney believe he was potentially unfairly targeted by some who disagreed with his views or outside work as a pastor.

First Liberty filed a complaint with the Equal Employment Opportunity Commission (EEOC), but before receiving an official response, St. Philips College issued the reinstatement.

Kayla Toney, associate Counsel at First Liberty Institute, told CBN News her legal firm was initially outraged after initially finding out about Varkeys plight, noting the fact his speech had been targeted was deeply concerning.

There were many First Amendment violations that we saw right away, first his religious exercise, Toney said. He is a committed Christian; hes also a pastor in addition to his role as a biology professor. So, we think there was some religious targeting by students who knew he was a pastor and thought they could accuse him of something like religious preaching.

The attorney said her client was simply teaching straight from the textbook and following those lesson plans that he had used for 19 years.

Beyond that, Toney cited academic freedom concerns at the center of the case, arguing professors like Varkey should be free to teach from textbooks without fear of reprisal.

We also saw some due process concerns that Dr. Barkey never had the opportunity to meet with the students who were upset, or learn what their complaints were, or have a conversation, even with his supervisor, which was part of the colleges own procedures for a complaint or a termination, she said.

Varkey could return to the classroom as soon as this spring, with Toney noting the EEOC complaint will be dismissed as part of the settlement pending he is able to teach again as planned.

The professor said he hopes his successful quest to fight for his job will inspire other Christians who might face similar issues and barriers.

I would say, dont quit, because there are people very supportive just like First Liberty, he said, urging people to be brave and take a stand. Stand for the truth.

Original post:

Fired Biology Professor Fights Back and Wins, Has a Message For Fellow Christians - CBN.com